<p>Baseline characteristics of patients in the VKA group and the dabigatran group.</p
<p>Baseline characteristics of patients according to baseline serum ALP tertile.</p
Baseline characteristics of the subset of subjects with CKD-MBD measurements according to study grou...
<p>Baseline characteristics of the example dataset of patients with manifest vascular disease.</p
<p>Baseline characteristics for the patients in the <5 drugs and ≥5 drugs subgroups.</p
Baseline characteristics of the patients in the aleglitazar group compared with the placebo group.</...
Baseline parameters in the different groups prior to oral dabigatran treatment.</p
<p>Baseline characteristics of patients in the antiviral group and the non-antiviral group.</p
<p>Baseline patient characteristics in pre-matched and propensity-matched groups.</p
<p>Baseline characteristics of patients in the included Randomized Clinical Trials.</p
<p>Baseline characteristics of the patients and established etiological diagnosis.</p
<p>Baseline characteristics of study participants according to diagnostic groups.</p
<p>Continuous variables are presented as means ± SD, while categorical variables are expressed as nu...
<p>Baseline characteristics of patients, risk factors, clinical severity and diagnosis.</p
<p>Baseline characteristics between patients with Recovered (R-), Persistent (P-) AKI and Control Gr...
Baseline characteristics of the patients in the per-protocol population (n = 54).</p
<p>Baseline characteristics of patients according to baseline serum ALP tertile.</p
Baseline characteristics of the subset of subjects with CKD-MBD measurements according to study grou...
<p>Baseline characteristics of the example dataset of patients with manifest vascular disease.</p
<p>Baseline characteristics for the patients in the <5 drugs and ≥5 drugs subgroups.</p
Baseline characteristics of the patients in the aleglitazar group compared with the placebo group.</...
Baseline parameters in the different groups prior to oral dabigatran treatment.</p
<p>Baseline characteristics of patients in the antiviral group and the non-antiviral group.</p
<p>Baseline patient characteristics in pre-matched and propensity-matched groups.</p
<p>Baseline characteristics of patients in the included Randomized Clinical Trials.</p
<p>Baseline characteristics of the patients and established etiological diagnosis.</p
<p>Baseline characteristics of study participants according to diagnostic groups.</p
<p>Continuous variables are presented as means ± SD, while categorical variables are expressed as nu...
<p>Baseline characteristics of patients, risk factors, clinical severity and diagnosis.</p
<p>Baseline characteristics between patients with Recovered (R-), Persistent (P-) AKI and Control Gr...
Baseline characteristics of the patients in the per-protocol population (n = 54).</p
<p>Baseline characteristics of patients according to baseline serum ALP tertile.</p
Baseline characteristics of the subset of subjects with CKD-MBD measurements according to study grou...
<p>Baseline characteristics of the example dataset of patients with manifest vascular disease.</p
DOI
Add to ORKG